---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-26-036006"
form_type: "8-K"
ticker: "SSII"
cik: "0001676163"
company_name: "SS Innovations International, Inc."
filed_at: "2026-03-30T23:59:59+00:00"
generated_at: "2026-05-15T08:24:08.585248+00:00"
event_type: "regulatory"
sentiment: "positive"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# SSi Mantra approved in Colombia, Oman, Sri Lanka, Kenya; total approvals now 11 countries

## Summary
- Regulatory approvals from INVIMA (Colombia, Nov 2025), DGPA&DC (Oman, Nov 2025), NMRA (Sri Lanka, Jan 2026), and PPB (Kenya, Jan 2026).
- Cumulative installed base of SSi Mantra reached 168 systems across 10 countries as of Dec 31, 2025.
- Cumulative surgeries total 7,885 including 390 cardiac and 121 pediatric; over 150 telesurgeries performed.
- Company anticipates FDA 510(k) decision by mid-2026 and CE marking in 2026 for SSi Mantra.

## SEC filing metadata
- accession: 0001213900-26-036006
- form_type: 8-K
- ticker: SSII
- cik: 0001676163
- company_name: SS Innovations International, Inc.
- filed_at: 2026-03-30T23:59:59+00:00
- event_type: regulatory
- sentiment: positive
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1676163/000121390026036006/0001213900-26-036006-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1676163/000121390026036006/ea0283970-8k_ssinnova.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-26-036006
- JSON: https://secwatch.observer/filing/0001213900-26-036006.json
- Plain text: https://secwatch.observer/filing/0001213900-26-036006.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.